A Search Service for Abbreviation / Long Form

â–  Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 390
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IC
Long Form : inspiratory capacity
No. Year Title Co-occurring Abbreviation
2020 Absence of dynamic hyperinflation during exhaustive exercise in severe COPD reflects submaximal IC maneuvers rather than a nonhyperinflator phenotype. FIVC
2020 The Prevalence of Expiratory Flow Limitation in Youth Elite Male Cyclists. CON, EFL, ET, FEV1, FVC, MFVL, PEF
2020 Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate Improves Inspiratory Capacity in Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap. ACO, ACQ, BUD/FORM, CAT, COPD, FeNO, GLY
2019 Area under the forced expiratory flow-volume loop in spirometry indicates severe hyperinflation in COPD patients. AreaFE, ROC, RV/TLC
2019 Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial. BE-COPD, IND, TIO, WD
2019 Can a physical activity similar to activities of daily living cause dynamic hyperinflation and change the thoracoabdominal configuration in patients with chronic obstructive pulmonary disease? DH, ERV, OEP
2019 Developing a New Marker of Dynamic Hyperinflation in Patients with Obstructive Airway Disease - an observational study. COPD, EELV, TLC
2019 Difference Between Slow and Forced Vital Capacity and Its Relationship with Dynamic Hyperinflation in Patients with Chronic Obstructive Pulmonary Disease. 6MWT, COPD, DH
2019 Effect of weight loss via bariatric surgery for class III obesity on exertional breathlessness. ---
10  2019 Efficacy of tiotropium and olodaterol combination therapy on dynamic lung hyperinflation evaluated by hyperventilation in COPD: an open-label, comparative before and after treatment study. 6MWD, CAT, COPD, DLH, FEV1, MPIH
11  2019 Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model. ECM, FVC, TLC, VC
12  2019 Human diaphragm atrophy in amyotrophic lateral sclerosis is not predicted by routine respiratory measures. ALS, SNIP, VC
13  2019 Inspiratory Capacity and Vital Capacity of Healthy Subjects 9-81 Years of Age at Moderate-High Altitude. VC
14  2019 Investigating the relationships among lung function variables in chronic obstructive pulmonary disease in men. COPD, FRC, FVC, RV, TLC
15  2019 Is the Metronome-Paced Tachypnea Test (MPT) Ready for Clinical Use? Accuracy of the MPT in a Prospective and Clinical Study. COPD, CPET, DH, MPT
16  2019 Longitudinal change of FEV1 and inspiratory capacity: clinical implication and relevance to exacerbation risk in patients with COPD. TLC
17  2019 Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. COPD, DLCO, FEV1
18  2019 Measurement of Dynamic Hyperinflation During the 6-Minute Walk Test Using a Mobile Device. 6MWT
19  2019 Positive expiratory pressure breathing speeds recovery of postexercise dyspnea in chronic obstructive pulmonary disease. COPD, DH, PEP
20  2019 Restoration of cough via spinal cord stimulation improves pulmonary function in tetraplegics. MEP, MIP, SCI, SCS, TLC
21  2019 Sensory consequences of critical inspiratory constraints during exercise in pulmonary arterial hypertension. IRV, VE
22  2019 Simple standard equation for daily step count in Japanese patients with chronic obstructive pulmonary disease. ---
23  2019 Statistical Process Control Improves The Feasibility Of Remote Physiological Monitoring In Patients With Chronic Obstructive Pulmonary Disease. AC, COPD, RPM, SD, SPC
24  2019 The impacts of parity on lung function data (LFD) of healthy females aged 40 years and more issued from an upper middle income country (Algeria): A comparative study. BMI, LFD, MMEF, PEF, RV/TLC, sRaw, TGV
25  2019 The value of high-resolution computed tomography (HRCT) to determine exercise ventilatory inefficiency and dynamic hyperinflation in adult patients with cystic fibrosis. AT, AWT, CF, CPET, DH, HRCT, IC/TLC, MP, Vef
26  2019 Thoracoabdominal asynchrony and paradoxical motion in middle stage amyotrophic lateral sclerosis. AB, ALS, CPF, FVC, IPRCa, Rca, TAA
27  2019 Usefulness of a Newly Developed Spirometer to Measure Dynamic Lung Hyperinflation following Incremental Hyperventilation in Patients with Chronic Obstructive Pulmonary Disease. COPD, DLH
28  2019 [Analysis of the overweight and obesity effects on pulmonary function in OSA patients]. ERV, FRC, MV, PEF, RV, VC
29  2018 A randomized study using functional respiratory imaging to characterize bronchodilator effects of glycopyrrolate/formoterol fumarate delivered by a metered dose inhaler using co-suspension delivery technology in patients with COPD. FEV1, FRC, FRI, HRCT, iRaw, iVaw, RV, siRaw, siVaw
30  2018 Body plethysmography in chronic obstructive pulmonary disease patients: A cross-sectional study. CN, COPD, RV, SM, TLC
31  2018 Cardiorespiratory repercussions according to the abdominal circumference measurement of men with obstructive respiratory disorder submitted to respiratory physiotherapy. AC, AI, DBP, HRV, SVC
32  2018 CPAP and EPAP elicit similar lung deflation in a non-equivalent mode in GOLD 3-4 COPD patients. CPAP, EPAP
33  2018 Dynamic hyperinflation during the 6-min walk test in severely asthmatic subjects. 6MWT, COPD
34  2018 Effect of Pulmonary Rehabilitation on Inspiratory Capacity During 6-min Walk Test in Patients With COPD: A PROSPECTIVE CONTROLLED STUDY. 6MWT, CAT, COPD, CTG, PR, PRG, SGRQ
35  2018 Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting beta2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan. CAT, LABA, LAMA, LAMA
36  2018 Efficacy and safety of four doses of glycopyrrolate/formoterol fumarate delivered via a metered dose inhaler compared with the monocomponents in patients with moderate-to-severe COPD. AUC0-12, FEV1, FF, GP
37  2018 Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity. ---
38  2018 Exertional dyspnea and operating lung volumes in asthma. IRV
39  2018 Impact of neurological level and spinal curvature on pulmonary function in adults with spina bifida. ERV, FEV1, FVC, SB, TLC
40  2018 Is daily physical activity affected by dynamic hyperinflation in adults with cystic fibrosis? CF, CPET, DPA, EELV
41  2018 LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review. ET, FDCs, FEV1, ICS, LABA, LAMA, SGRQ, TDI
42  2018 Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis. ET
43  2018 Low exertional inspiratory capacity is not related to dynamic inspiratory muscle weakness in heart failure. CHF, Pes
44  2018 NON-INVASIVE PREVENTIVE VENTILATION WITH TWO PRESSURE LEVELS IN THE POSTOPERATIVE PERIOD OF ROUX-EN-Y GASTRIC BYPASS: RANDOMIZED TRIAL. MV, PEF, POD, VC
45  2018 Pulmonary Function Difference in Sasang Constitutional Types. ERV, FEV1, FVC, IRV, PFTs, SCAT, SE, SY, TE
46  2018 Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPD. COPD, EET, RV, TLC, UMEC
47  2018 Role of bronchodilation and pattern of breathing in increasing tidal expiratory flow with progressive induced hypercapnia in chronic obstructive pulmonary disease. COPD, EELV, FEV1, HC, MRA, Pes, VL
48  2018 Static and dynamic hyperinflation during severe acute exacerbations of chronic obstructive pulmonary disease. COPD
49  2018 The Mozart study: a relation between dynamic hyperinflation and physical activity in patients with chronic obstructive pulmonary disease? COPD, DH, MPT, PA, SH
50  2018 The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis. CF, RV
51  2017 ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD. BI, FRC
52  2017 Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test. CPET, DH
53  2017 Assisted vital capacity to assess recruitment level in neuromuscular diseases. ERV, MI-E, NMD, VC
54  2017 Bronchodilator Response Assessment of the Small Airways Obstructive Pattern. IOS, SAOP
55  2017 Effect of pulmonary rehabilitation on tidal expiratory flow limitation at rest and during exercise in COPD patients. DH, EFL, NEP, PR, SGRQ
56  2017 Effects of combination therapy indacaterol/glycopyrronium versus tiotropium on moderate to severe COPD: evaluation of impulse oscillometry and exacerbation rate. FEV1, FVC, IND/GLY, IOS
57  2017 Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial. COPD, FRC, RV, sRaw
58  2017 Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis. ET, SUCRA
59  2017 Impaired Pulmonary Function is an Additional Potential Mechanism for the Reduction of Functional Capacity in Clinically Stable Fontan Patients. DLCO, FP, FVC, HC, MIP, SNIP, TLC
60  2017 In-vivo analysis of sternal angle, sternal and sternocostal kinematics in supine humans during breathing. ALs, FRC, JPP, MIC, SCJ, TLC
61  2017 Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study. CI, COPD, FEV1, FVC, GLY, IND, TLC
62  2017 Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension. CTEPH
63  2017 Longitudinal changes in lung hyperinflation in COPD. FEV1, RV, TLC
64  2017 Lung characteristics in elderly males and females patients with COPD: differences and optimal use of dry powder inhalers (DPIs). DPIs, MEP, MIP, PIF
65  2017 Parasternal intercostal muscle activity during methacholine-induced bronchoconstriction. FEV1
66  2017 Pulmonary mechanic and lung histology induced by Crotalus durissus cascavella snake venom. C. d. cascavella, Cst, MCh, RN
67  2017 Reference values for pulmonary diffusing capacity for adult native Finns. DLCO/VA, ECSC, IVC, VA, VC
68  2017 Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis. CF, EOT, RV, TLC, VC
69  2017 Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study. CC, EI, FEV1, LAA, mMRC, OR
70  2017 Sex Differences in the Effects of Obesity on Lung Volume. BMI, ERV, FRC, FRC, VC
71  2017 The effect of N-acetylcysteine on exacerbations of chronic obstructive pulmonary disease: A meta-analysis and systematic review. CI, FEV1, FVC, NAC, RR
72  2017 The Link between Reduced Inspiratory Capacity and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. ---
73  2016 Bronchodilator response of advanced lung function parameters depending on COPD severity. BP, FEV1, FVC
74  2016 Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD. COPD, GP, MDI
75  2016 Effect of Eight-Week Aerobic, Resistive, and Interval Exercise Routines on Respiratory Parameters in Non-Athlete Women. ERV, FVC, IRV, PFT, PIF, VC, VT
76  2016 Effectiveness of prophylactic non-invasive ventilation on respiratory function in the postoperative phase of pediatric cardiac surgery: a randomized controlled trial. MIP, MV, NIV, PEF, POD, RR, SVC, TV
77  2016 Effects of a multidisciplinary body weight reduction program on static and dynamic thoraco-abdominal volumes in obese adolescents. MBWRP, RMET
78  2016 Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study). COPD, FEV1, IND/GLY, OD
79  2016 Efficacy of non-invasive ventilation as a rescue therapy for relieving dyspnea in patients with stable severe COPD. COPD, NIV
80  2016 Efficiency of neural respiratory drive for the assessment of bronchodilator responsiveness in patients with chronic obstructive pulmonary disease: an exploratory study. COPD, FEV1, FVC, NRD, RMS, VE
81  2016 Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD. COPD, TLC, VCO2
82  2016 Relationship between costovertebral joint kinematics and lung volume in supine humans. CVJ, FRC, MIC, TLC
83  2016 Respiratory Factors Contributing to Exercise Intolerance in Breast Cancer Survivors: A Case-Control Study. ---
84  2016 The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study). AUC0-12h, BDP/FF, GB, LAMA, pMDI
85  2015 Alternative functional criteria to assess airflow-limitation reversibility in asthma. FVC, RV
86  2015 Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study. COPD, CV, FEV1
87  2015 Determination of 'recruited volume' following a PEEP step is not a measure of lung recruitability. ARDS, LH, PEEP
88  2015 Determining the Role of Dynamic Hyperinflation in Patients with Severe Chronic Obstructive Pulmonary Disease. COPD, MPT, TLC
89  2015 Dynamic hyperinflation during activities of daily living in COPD patients. ADLs, COPD, DH, ECTs, FEV1
90  2015 Free-living physical activity characteristics, activity-related air trapping and breathlessness, and utilization of transtheoretical constructs in COPD: A pilot study. COPD, MDP, PA
91  2015 Impact of anaemia on lung function and exercise capacity in patients with stable severe chronic obstructive pulmonary disease. COPD, CPET, FEV1, FVC, Hb, PFT, RV, TLC, VE
92  2015 Inspiratory Capacity as an Indirect Measure of Immediate Effects of Positive Expiratory Pressure and CPAP Breathing on Functional Residual Capacity in Healthy Subjects. FRC, PEP, TLC
93  2015 Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD. FEV1, MEWS
94  2015 Peak oxygen uptake and breathing pattern in COPD patients--a four-year longitudinal study. COPD, CPETs, VT
95  2015 Physiological and perceptual responses to incremental exercise testing in healthy men: effect of exercise test modality. fR, IRV, Pga,peak, VT
96  2015 Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients. 6MWD, 6MWT, COPD, DH, MMRC, SGRQ
97  2015 Pulmonary function before and after the Nuss procedure in adolescents with pectus excavatum: correlation with morphological subtypes. ANCOVA, FVC, PEF, RV, TLC, VC
98  2015 Pursed lip breathing improves exercise tolerance in COPD: a randomized crossover study. CB, COPD, DH, PLB
99  2015 [Characteristics of subgroups classified by pulmonary function test in chronic obstructive pulmonary disease patients]. COPD
100  2014 A comparison of cardiopulmonary exercise test and 6 minute walking test in determination of exercise capacity in chronic obstructive pulmonary disease. 6MWT, COPD, CPET, MVV